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Abstract
 .The NADH-ubiquinone oxidoreductase type I NDH of Rhodobacter capsulatus is a multisubunit enzyme encoded by
the 14 genes of the nuo operon. This bacterial enzyme constitutes a valuable model for the characterization of the
 .mitochondrial Complex I structure and enzymatic mechanism for the following reasons. i The mitochondria-encoded ND
subunits are not readily accessible to genetic manipulation. In contrast, the equivalents of the mitochondrial ND1, ND2,
 .ND4, ND4L, ND5 and ND6 genes can be easily mutated in R. capsulatus by homologous recombination. ii As illustrated
in the case of ND1 gene, point mutations associated with human cytopathies can be reproduced and studied in this model
 .  .system. iii The R. capsulatus model also allows the recombinant manipulations of iron–sulfur Fe–S subunits and the
assignment of Fe–S clusters as illustrated in the case of the NUOI subunit the equivalent of the mitochondrial TYKY
.  .subunit . iv Finally, like mitochondrial Complex I, the NADH-ubiquinone oxidoreductase of R. capsulatus is highly
 .sensitive to the inhibitor piericidin-A which is considered to bind to or close to the quinone binding site s of Complex I.
Therefore, isolation of R. capsulatus mutants resistant to piericidin-A represents a straightforward way to map the inhibitor
 .binding sites and to try and define the location of quinone binding site s in the enzyme. These illustrations that describe the
interest in the R. capsulatus NADH-ubiquinone oxidoreductase model for the general study of Complex I will be critically
developed in the present review. q 1998 Elsevier Science B.V.
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1. Introduction
The high complexity of mitochondrial NADH-
 .ubiquinone oxidoreductase Complex I has prompted
some authors to look for related but simpler bacterial
enzymes. Bacterial NADH-ubiquinone oxidoreduc-
 .tases also called NDHs for NADH dehydrogenases
 .can be classified into at least three categories: i the
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Hq-pumping NADH-ubiquinone oxidoreductases or
w x  .type I NDHs 1 , ii the uncoupled NADH-
w xubiquinone oxidoreductases or type II NDHs 2 and
 . qiii the Na -pumping NADH-ubiquinone oxidore-
w xductases 3 . Only type I NDHs display high struc-
tural and functional similarities with the mitochon-
drial Complex I and can thus be used as a model
system for the study of this enzyme. Purple non-sulfur
bacteria such as Rhodobacter capsulatus are consid-
ered to be phylogenetically related to the ancestor
w xfrom which mitochondria derived 4 . The presence
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of a type I NADH-dehydrogenase activity in R.
capsulatus has been reported quite a long time ago
w xby Baccarini-Melandri et al. 5 who demonstrated
the presence of an energy coupling site I in the
membranes of this bacteria. They also showed that
the NADH-dehydrogenase activity associated with
this energy coupling site was 95% sensitive to
rotenone. In this regard R. capsulatus type I NDH is
very similar to the eukaryote Complex I and thus
constitutes an interesting model for the study of this
enzyme. More recently, the authors of the present
review identified an nuo operon encoding this multi-
w xsubunit enzyme 6,7 . As will be discussed below, the
genes clustered in this nuo operon code for 14
proteins homologous to 14 major subunits of the
mitochondrial enzyme. Like the type I NDHs of
Escherichia coli, Paracoccus denitrificans and Ther-
w xmus thermophilus HB-8 8–10 , the enzyme of R.
capsulatus appears to be a kind of minimal system in
comparison to mitochondrial Complex I. Further-
more, compared to the mitochondrial Complex I and
to the other bacterial models, the NADH-ubiquinone
oxidoreductase of R. capsulatus has specific advan-
tages that will be illustrated and discussed in this
review. For the sake of simplicity, R. capsulatus
NADH-ubiquinone oxidoreductase will be called R.
capsulatus Complex I in the following.
2. Structure of R. capsulatus Complex I
2.1. Structural features of the subunits of the R.
capsulatus Complex I
Historically, two different strategies were followed
to clone the operons encoding the bacterial NADH-
ubiquinone oxidoreductases. In the case of P. denitri-
ficans, the isolation and biochemical characterization
of a partial Complex I preceded the identification of
w xthe nqo operon 9 . In contrast to this, the identifica-
tion of the R. capsulatus nuo operon really consti-
tuted the first step towards the molecular characteri-
zation of R. capsulatus Complex I. Based on the
assumption that the TYKY subunit identified in
bovine Complex I must be highly conserved among
organisms, part of a gene of R. capsulatus poten-
tially encoding a peptide homologous to TYKY was
w xamplified by PCR 6 . This PCR product was used as
a probe for screening a lambda genomic library.
From the sequence of the isolated clones it has been
possible to generate a nearly 20-kbp contig contain-
 .ing at least 23 open reading frames orfs . Fourteen
out of these orfs code for subunits of the R. capsula-
 .tus Complex I Table 1 . The identity of these nuo
genes has been mainly assigned by comparing their
sequences or that of their products with the bovine
mitochondrial sequenced cDNA or proteins or with
the P. denitrificans genes. In R. capsulatus as in all
other known bacterial systems, the nuo genes are
 .clustered in the bacterial chromosome Fig. 1 . The
R. capsulatus gene cluster has been located on a high
resolution genetic map in a region also containing the
puc cluster encoding the polypeptides of the light
. harvesting complex II and the fru cluster encoding
the component of the fructose transport and uptake
. w x Xsystem 12 . At its 5 end, the nuo cluster is bor-
dered by one unidentified reading frame located nearly
300 bp upstream of nuoA. On the other extremity,
nuoN gene is immediately followed by the urfR242
which potentially encodes a protein homologous to
the catalytic domain of the E. coli biotin acetyl-CoA
. w xcarboxylase ligase 13 . Definitive demonstration that
all the clustered nuo genes belong to the same tran-
scriptional unit has not been obtained so far. Never-
theless, we assume that these genes are part of an
operon coding for all the components of the Complex
I. Indeed, upstream the nuoA gene, three putative
consensus promotor motifs can be spotted. At the
opposite boundary of this gene cluster, about 400 bp
downstream of the nuoN gene, the 3X part of the
sequenced fragment contains a motif which is able to
form a very stable stem and loop structure at the level
w xof the RNA 7 . This structure includes a GC rich
motif and a T sequence and is similar to sequences5
believed to play the role of a rho-independent termi-
w xnation signal for transcription 14,15 . As a conse-
quence, the urfR242 must not be considered as part
of the nuo operon which is probably transcribed as a
single polycistronic RNA potentially encoding up to
21 polypeptides. The size of this R. capsulatus operon
from the nuoA ATG start codon to the nuoN stop
.codon is 18 345 bp. It is the longest NADH-
ubiquinone oxidoreductase bacterial operon se-
quenced so far. The GqC content of the correspond-
ing genes is in the range of 58 to 72%. As stated

















Characteristics of the polypeptides potentially encoded by R. capsulatus nuo operon
Nucleotide position Amino Molecular Bovine Putative Conserved % Sequence % Sequence
aof gene in acid masses equivalent membranous cysteines homologies homologies
 .nuo operon number Da domains BovrRc PdrRc
nuoA 353–730 126 14 235 ND3 3 60 94
nuoB 724–1254 177 19 507 20 1? 5 90 97
nuoC 1269–1865 199 23 089 30 73 85
nuoD 1914–3152 413 46 446 49 1 79 94
nuoE 3155–4321 389 41 257 24 4 67 86
urf1 4424–4864 147 14 796
nuoF 5060–6352 431 47 130 51 9 86 95
urf2 6362–6835 158 17 012
urf3 6838–7119 94 9612
urf4 7119–7889 257 28 910
nuoG 7950–9944 665 71 258 75 12 70 92
urf5 9951–10355 135 13 629
nuoH 10 392–11426 345 37 850 ND1 8–9 64 91
urf6 11 432–11710 93 10 035
nuoI 11 713–12201 163 18 846 23 8 90 96
urf7 12 201–12608 136 15 214
nuoJ 12 608–13213 202 21 732 ND6 5 18 87
nuoK 13 260–13565 102 10 983 ND4L 3 27 99
nuoL 13 573–15708 712 77 527 ND5 15–16 57 90
nuoM 15 711–17246 512 55 753 ND4 14 52 93
nuoN 17 262–18695 478 50 124 ND2 13–14 25 88
Genes of the R. capsulatus nuo operon and features of the expressed subunits are presented in the first four columns. Comparisons of the R. capsulatus subunits with the
 .bovine and P. denitrificans equivalent subunits were performed by the clustal method matrix PAM250 using DNA star multialignment software.
aConserved cysteines in bovine, P. denitrificans and R. capsulatus subunits. Bov sbovine, Rcs R. capsulatus, Pds P. denitrificans.
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 w xFig. 1. Comparison of the different bacterial nuornqo operons. R. capsulatus operon Refs. 6,7,11,21 and this issue; GenBank
.  .accession number: AF029365 differs from the other known operons by the presence of seven orfs urf1 to urf7 . Only R. capsulatus urf5
and urf7 display a significant homology with P. denitrificans urf4 and urf6, respectively. Another particularity of R. capsulatus nuo
operon is the atypical length of the R. capsulatus nuoE gene leading to a 150 amino acid extension at the C-terminus of NUOE subunit.
 w x w x w x.P. denitrificans nqo operon 9 , E. coli nuo operon 8 , T. thermophilus nqo operon 10 .
operon exhibit clear homologies with their mitochon-
drial counterparts. The seven remaining orfs have
been called urf1-7 and might potentially code for
polypeptides with molecular masses in the range of
9.6 to 28.9 kDa. The P. denitrificans equivalent nqo
w xoperon contains six orfs 9 . The orfs are located in
five different intergenic regions in R. capsulatus but
in only four intergenic regions in P. denitrificans.
Interestingly, four orf-containing intergenic regions,
located between the nuoE and nuoF genes nqo2–
.nqo1, respectively in P. denitrificans ; between nuoF
 .and nuoG nqo1–nqo3 ; between nuoG and nuoH
 . nqo3–nqo8 and between nuoI and nuoJ nqo9–
.nqo10 are common to P. denitrificans and R. cap-
sulatus. However, the number of orfs in these regions
varies from one to three depending on the species.
The additional orf-containing intergenic region of R.
capsulatus is located between nuoH and nuoI. Only
the putative products of the R. capsulatus urf5 and
urf7 show significant homologies with the products
of the P. denitrificans urf4 and urf6, respectively
urf5 and urf6 of P. denitrificans are actually related
.to each other . All the other urfs are poorly or not at
all similar to the ones found in P. denitrificans. The
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role of the putative products of these urfs, if they are
expressed, is unknown. They may be related to the
metabolic specificity of R. capsulatus: the difference
with P. denitrificans is that R. capsulatus is a photo-
w xsynthetic bacteria. On this regard, Herter et al. 11
noted that R. capsulatus urf4 putative gene product
displays similarities with subunit M of Rhodopseu-
domonas ˝iridis photosynthetic reaction center. Ac-
cording to these authors, this putative peptide present
an ATPrGTP binding domain and might be part of a
regulatory system.
When expressed, the 14 nuo genes give rise to
polypeptides whose features are reported in Table 1.
In the absence of polypeptide maturation or modifica-
tion and assuming that only one copy of each of the
 .14 expressed proteins NUOA to NUON is assem-
bled into Complex I, it can be calculated that R.
capsulatus Complex I is a multimeric enzyme com-
posed of 4914 amino acids exhibiting a molecular
mass of nearly 536 kDa. Sequence similarities of the
subunit of Complex I with related enzymatic systems
suggest that this system emerged from the association
of different preexisting enzymes. It has been put
forward that nuoB, nuoD, nuoH, nuoI, nuoL, nuoM
and nuoN genes are affiliated to the hyc operon
which encodes the formate hydrogenlyase of E. coli
and the central part of the nuo operon including
nuoE, nuoF and nuoG has been related to the NAD-
dependent soluble hydrogenase encoded by the hox
w xoperon in Alcaligenes eutrophus 16,17 . Actually,
the comparison can be further extended to the NUOC
subunit equivalent to the 30 kDa mitochondrial sub-
.unit which displays a striking similarity to the N-
terminal part of the hycE product. This subunit of the
formate hydrogenlyase is thus equivalent to a
NUOC–NUOD chimera. Such a chimeric NUOC–
NUOD subunit was found in the Complex I of the
w xBuchnera aphidicola bacteria 18 .
2.1.1. ND-like subunits of the R. capsulatus
Complex I
Seven nuo genes are equivalent to the mitochon-
drial nd genes. These are nuoA, nuoH, and nuoJ to
nuoN. Like the other bacterial nuornqo operons
known so far, the R. capsulatus operon is character-
ized by the fact that six out of the seven genes,
equivalent to the mitochondrial genes coding for the
ND subunits of the Complex I, are clustered at the 3X
end of the operon. Only nuoA, the nd3 equivalent
gene, is located at the very beginning of the operon.
All the ND subunits are hydrophobic in nature and
constitute the membranous domain of the Complex I
or at least one major subdomain of it. Their role in
the proton pumping activity of Complex I is probably
prominent. If we assume that a complex made up of
only the protonophoric part of Complex I could work
as an uncoupled proton channel when freely assem-
bled, the existence of such an hydrophobic domain
may be highly toxic for the cells. It is possible to
hypothesize that the sequential expression of the
operon associated with a sequential assembly of the
hydrophillic subunits as well as the NUOA subunit at
the level of the membrane could prevent the assem-
bly of a free transmembranous domain made up of
ND-like subunits alone. It can be noted that, in the
case of the unc operon encoding the bacterial Hq-
ATPase, a similar organization clustering the genes
uncA, uncB and uncC, that encodes the hydrophobic
part of the enzyme is also observed. However, in this
case, uncA, uncB and uncC are found either in the 5X
part of the nuo operon or at a different locus, depend-
w xing on the bacterial species 14 . The R. capsulatus
subunits NUOJ, NUOK and NUON are the least
conserved subunits of the enzyme and are less than
30% homologous to their mitochondrial equivalents
 .ND6, ND4L and ND2 subunits, respectively . R.
capsulatus ND equivalent subunits individually con-
tain between three to up to 16 putative transmembra-
 .nous domains Table 1 . Thus it can be predicted that
the total number of transmembranous domains which
are part of the R. capsulatus Complex I is potentially
in the range of 61 to 64 per enzyme complex.
2.1.2. The other subunits of the R. capsulatus
Complex I
Among the seven other subunits NUOB–NUOG
.and NUOI , three have extremely well-conserved se-
quences in R. capsulatus in comparison to the bovine
subunits. These are the NUOB subunit PSST equiva-
.  .lent , the NUOF subunit 51 kDa equivalent and the
 .NUOI subunit TYKY equivalent . All three subunits
are more than 85% homologous to their bovine coun-
terpart. More details concerning NUOI are given in
Section 3.2. Previous structural analyses have pre-
dicted NUOB to be involved in the binding of a
 .putative iron–sulfur Fe–S cluster as it contains
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conserved cysteine residues. Indeed, four cysteines
C56, C57, C121 and C151, according to the R.
.capsulatus numbering are invariably conserved in
the E. coli, P. denitrificans and bovine equivalent
subunits. No histidine residues which could be in-
volved in iron coordination are conserved among
these sequences. The arrangement of these cysteines
does not look like any other consensus motif known
to be involved in the coordination of Fe–S cluster.
Secondary structure prediction indicates that at least
one region of the NUOB R. capsulatus subunit has a
high probability to be located in the membranous
domain. This hydrophobic region would encompass
the first two well-conserved C56 and C57 cysteines.
A transmembranous location of these cysteines could
probably impair Fe–S coordination or else might lead
to the generation of an unusual redox group which
might play an important role in the activity of the
whole enzyme.
The R. capsulatus NUOF subunit contains two
motifs that are predicted to be involved in the binding
w xof NADH and FMN 16 . Multiple alignments made
with the sequences of the 51-kDa subunit equivalents
from the mammalian mitochondria, lower eukaryotic
mitochondria and P. denitrificans show that these
subunits contain a total of nine conserved cysteines.
However, the total number of conserved cysteines
drops down to five when the sequences of the NUOF
equivalent subunits of E. coli and T. thermophilus
are taken into consideration. It is not known at pre-
sent if the four additional and well-conserved cys-
teines in the R. capsulatus NUOF subunit and in the
other mitochondrial equivalent subunits take part in
Fe–S coordination.
When compared to their bacterial and mitochon-
drial equivalents, NUOC and NUOD subunits exhibit
no specific features. The R. capsulatus NUOG sub-
unit is closely related to the mitochondrial equivalent
subunit 75 kDa. A total of 12 cysteine residues are
strictly conserved in the R. capsulatus NUOG sub-
unit, P. denitrificans NQO3 subunit and 75 kDa
mitochondrial subunits and are probably involved in
the ligation of three Fe–S clusters. The first of these
12 cysteines is not conserved in the T. thermophilus
 .equivalent subunit Fig. 2 . Surprisingly, the E. coli
and T. thermophilus subunits contain an additional
w xconserved motif of four cysteines 19,10 . The num-
ber of clusters bound to the enterobacterial and ar-
chaebacterial NUOG subunits has not yet been de-
fined but it is clear that these subunits are structurally
distinct from the R. capsulatus and mitochondrial
equivalent subunits.
Finally, the NUOE subunit is the most peculiar
subunit of R. capsulatus NADH-ubiquinone oxido-
reductase. The N-terminal part of this subunit is
highly conserved between R. capsulatus and other
species especially at the level of the four cysteine
w xresidues which are liganding one 2Fe–2S cluster
 . w xeither N1a or N1b 17,20 . However, this subunit
has a very unusual size in R. capsulatus. In compari-
son to the bovine subunit, the NUOE subunit is
extended at the C-terminus by more than 150 amino
acids leading to a molecular mass of 41.3 kDa while
w xthe bovine subunit is close to 24 kDa 11,21 . This
extension displays some similarities with P. denitrifi-
w xcans urf2 11 .
2.1.3. The missing subunits
The bacterial NADH-ubiquinone oxidoreductase,
composed of only 14 subunits, has a proton pumping
efficiency similar to that of mitochondrial Complex I
w x22 . This raises the question of the function of the
supernumerary subunits of mitochondrial Complex I.
It seems most probable that these supernumerary
subunits are not involved in the fundamental enzyme
mechanism but would rather add extra properties
such as an increased stability, an adaptation of the
Complex I biogenesis to mitochondrial compartmen-
tation, or a finer regulation of the enzymatic activity.
However, there are indications that some of these
supernumerary polypeptides such as the 9.5-kDa sub-
unit of N. crassa Complex I and the 14-kDa subunit
of the IP fraction of beef heart Complex I might be
directly involved in quinone binding. The purified 14
kDa subunit contains equistoichiometric amounts of
w xquinone 23 . As for the 9.5-kDa subunit, it was
labelled with a photoaffinity analog of quinone and is
thus considered to potentially bear an ubiquinone
w xbinding site 24 . However, these subunits are absent
in the bacterial enzyme although quinone binding
sites are obviously essential features of Complex I.
Two hypotheses can be put forward to explain the
 .photoaffinity labelling of the 9.5-kDa subunit: i
mitochondrial Complex I has evolved a more sophis-
ticated enzymatic mechanism involving extra quinone
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Fig. 2. Sequence comparison between mitochondrial and bacterial subunits equivalent to the bovine 75-kDa subunit. Only the first 340
amino acids of the R. capsulatus subunit have been aligned to the homologous segments of the equivalent proteins. Numbering
 .corresponds to the R. capsulatus sequence. Bov: bovine 75 kDa premature subunit Swiss-Prot accession number: P15760 ; Hum: human
 . 75 kDa premature subunit Swiss-Prot accession number: P28331 ; Ncr.: Neurospora crassa premature subunit Swiss-Prot accession
.  .number: P24918 ; Rc: R. capsulatus NUOG subunit GenBank accession number: AF029365 ; Pd: P. denitrificans NQO3 subunit
 .  .Swiss-Prot accession number: P29915 ; Tth: T. thermophilus NQO3 subunit Swiss-Prot accession number: Q56223 ; Ec: E. coli NUOG
 .subunit Swiss-Prot accession number: P33602 . Invariably conserved cysteine residues are double underlined. The first cysteine which is
not conserved only in T. thermophilus is marked by a diamond. The additional four cysteine cluster found only in E. coli and T.
thermophilus is indicated by open circles.
 .  .site s , ii alternatively, the azido photoreactive group
of the probe which is quite remote from the quinone
ring may react at some distance from the actual
quinone binding site.
2.2. Fe–S clusters of the Complex I of R. capsulatus
Complex I contains at least five EPR detectable
Fe–S clusters: two binuclear clusters, known as N1a
and N1b, and three tetranuclear clusters called N2,
N3 and N4. The physical properties of these clusters
as well as putative additional others have been re-
w xviewed by others 17,25 . In the bovine mitochondrial
Complex I, a number of nuclear-encoded subunits are
believed to contain Fe–S clusters. They are called
w xPSST, 24 kDa, 51 kDa, 75 kDa and TYKY 16 . The
first attempt to define the Fe–S clusters associated
with R. capsulatus Complex I was reported by Zan-
w xnoni and Ingledew 26 . By comparative potentio-
metric titrations of a mutant deprived of NADH-
ubiquinone oxidoreductase activity mutant M1 see
.below these authors observed that two EPR signals
at gs1.94 could be associated with Complex I.
These signals were characterized by a mid-point po-
tential of y115 and y370 mV. By comparison with
the midpoint potential of mitochondrial and P. deni-
w xtrificans Complexes I 25 , it can be proposed that the
first signal corresponds to cluster N2 and the lower
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potential signal might be similar to the midpoint
potential of cluster N1a. Actually, EPR and thermo-
dynamic parameters for the FeS clusters of Complex
I of R. sphaeroides—a bacteria closely related to R.
capsulatus—are remarkably similar to those of P.
w xdenitrificans and mitochondrial Complexes I 25 . In
the case of R. capsulatus, the M1 mutant has not
been genetically characterized and the specific alter-
ation of Complex I remains unclear. EPR studies of
the membranes of different nuo-disruption mutants or
of mutants altered in the Fe–S protein NUOI equiv-
.alent to the mitochondrial TYKY subunit evidenced
the clear association of clusters equivalent to mito-
 . chondrial clusters N1 g s1.935 , N2 g s1.92,x y x y
.  .g s2.05 and N3 g s1.86, g s1.933 with R.z x y
w x capsulatus Complex I 27,28 . Cluster N4 g values
.for the bovine enzyme: g s1.88, g s2.08 wasx z
difficult to observe due to large overlaps with cluster
 .N3 and with the intense Rieske signal g s1.89y
w xpresent in R. capsulatus membranes 27,28 .
2.3. Attempts to purify the Complex I of R. capsulatus
Most of the genetic studies developed with R.
capsulatus Complex I would greatly benefit from the
use of a preparation of pure Complex I. However, the
purification of this membranous enzyme is limited by
major drawbacks: firstly, the amount of Complex I
appears to be low compared to other respiratory
complexes in R. capsulatus. Secondly, most enzy-
matic assays used to characterize Complex I related
NADH oxidase activity can reveal other independent
NADH oxidase activities. Along this line, Oshima
w xand Drews 29 isolated a single polypeptide with
apparent NADH-2,6-dichloroindophenol oxidoreduc-
tase activity from R. capsulatus membranes. This
polypeptide has been assumed to constitute a type II
w xNDH 1 . However, genetic and biochemical data are
consistent with the fact that no type II NDH is
present in R. capsulatus, at least not when the bacte-
w xria are grown aerobically 11,21 . Actually, in our
hands, use of deamino-NADH in combination with
the short chain 2,3-dimethoxy-5-methyl-6-decyl-1,4-
 .benzoquinone decylUQ allows the specific detec-
tion of the NADH-ubiquinone oxidoreductase activity
of R. capsulatus Complex I. The main problem
encountered in the purification of the R. capsulatus
Complex I remains its instability upon detergent solu-
bilization. Such an instability seems to be a general
characteristic of bacterial type I NDHs: the procedure
for purification of P. denitrificans NADH-ubiquinone
w xoxidoreductase leads to a partial complex 30 and to
date, only E. coli type I NDH enzyme has been
reportedly purified to homogeneity in a stable form
w x19 . Even in this last case, most of the detergents
promote the dissociation of the enzyme and one has
to use acidic conditions and an alkylglucoside mix-
 .ture APG225 provided by Henkel, Germany to
prevent this effect. In the case of R. capsulatus, the
instability of the enzyme upon solubilization has been
consistently observed by three independent teams
w x11,21,31 . Two different strategies were used to
evaluate the integrity of the solubilized complex: one
way is to use centrifugation on sucrose gradient and
to look for the distribution of NADH-decylUQ activ-
w xity 11 . Alternatively, we have used subunit specific
antibodies such as anti-NUOE and anti-NUOI anti-
 . w xbodies to immunopurify associated subunit s 21 .
Using both strategies, independent screening of many
different detergents including glucopon 215 and 225
 .two commercial equivalents of APG225 did not
allow the isolation of a stable form of R. capsulatus
 w xComplex I Refs. 11,21 and Dupuis et al. unpub-
.lished results . Alteration of the pH between 6.5 and
8.5, as well as addition of many stabilizers such as
reducing agents, alcohols and polyols do not lead to
any clear stabilization of the enzyme. As APG225
proved adequate for E. coli NADH-ubiquinone
oxidoreductase isolation, further efforts were pursued
to try and isolate R. capsulatus Complex I with its
glucopon 215 and 225 equivalents. Two independent
attempts using different technical approaches, i.e.,
w ximmuno-purification in one case 21 and classical
w xchromatographic purification in the other case 11 ,
led to the isolation of the same small subcomplex
w xcomposed of subunits NUOE and NUOF 11,21 .
Like mitochondrial FP fraction, R. capsulatus
NUOE–NUOF subcomplex contains 0.7 mol of FMN
per mol and is able to catalyze NADH-ferricyanide
w xoxidoreduction 11 . The difficulties encountered in
R. capsulatus Complex I purification illustrate the
great difference of stability between the mitochon-
drial and the bacterial NADH-ubiquinone oxidore-
ductases. Such an instability of the bacterial type I
NDH compared to its mitochondrial equivalent might
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give a key to understand the relative complexity of
the mitochondrial enzyme: some of its ancillary sub-
units may have been added to stabilize the mitochon-
drial Complex I enzyme.
3. R. capsulatus, a powerful system for the genetic
study of Complex I
Although interesting models have been proposed
 w xto explain the mechanism of Complex I Refs. 32,33
.and Ohnishi’s contribution in this issue there is an
urgent need for the design of new experimental ap-
proaches to validate these models. The studies of the
mitochondrial respiratory Complexes III and IV have
largely benefited from fast spectroscopic techniques
compatible with the time scale of electron transfers.
Unfortunately, in the case of Complex I, the absence
of appropriate chromophores have precluded this kind
of approach and the time constants of procedures
such as rapid freezing and EPR do not allow the
dissection of the electron transfer process. There is
evidence for the existence of different inhibitor bind-
ing sites but we still have no clear evidence for the
existence of associated ‘intermediate states’. Genetic
approaches might be a way to solve these difficulties:
mutants altered at different points of the enzyme can
be expected to display altered enzymatic reactions
partial redox reaction, partial proton pumping or
uncoupling between redox reactions and proton
.pumping . . . thus allowing a dissection of the Com-
plex I mechanism. In this regard, the existence of
powerful genetics techniques to manipulate this bac-
w xteria 34 makes R. capsulatus an attractive model for
the genetic study of Complex I. This can be illus-
 .trated here by four different genetic approaches. i
First R. capsulatus mutants deficient at the level of
Complex I can be generated by interposon mediated
 .gene disruption Section 3.1 . Although these genetic
alterations are very coarse, they compare somewhat
to mitochondrial deletions associated with human
w xpathologies 35 . These mutants were helpful to de-
fine the growth phenotype of Complex I-deficient
mutants and constitute a valuable starting material for
 .further refined genetic studies. ii Such a refined
strategy is illustrated by the site directed mutagenesis
study of the putative Fe–S cluster insertion motifs of
 .  .the NUOI subunit Section 3.2 . iii Alternatively,
R. capsulatus can be used as a model system to study
point mutations of the mitochondrial ND genes asso-
ciated with pathologies such as the Leber’s disease
 .  .Section 3.3 . iv Finally, classical random mutagen-
esis constitutes a powerful approach to map the dif-
ferent inhibitors and quinone binding sites of the
 .Complex I Section 3.4 .
3.1. Genetic disruption of the nuo operon
The general procedure to alter R. capsulatus
genome makes use of bacterial conjugation with an
w xE. coli donor strain such as S17-1 36 . This allows
the transfer of either replicative plasmids such as
w xpRK415 37 for protein expression and complemen-
 .tation or non-replicative suicide plasmids such as
w xpPHU281 38 for homologous recombination. In the
present case, this last strategy was used to individu-
ally disrupt nuo genes by insertion of KIXX interpo-
w xson 39 . KIXX interposon presents two resistance
genes for kanamycin and bleomycin. It has no tran-
scription termination signal and its interposition in a
given gene is reputed to induce no or limited polar
effect on cotranscribed genes. In practice, gene dis-
ruption mutants are generated by legitimate double
cross-over between a circular suicide plasmide bear-
ing the targeted gene disrupted by KIXX and R.
capsulatus genome. Thus, the screening for such
mutants has to be conducted in two steps: first, all the
recombinants carrying the interposon constructed ei-
.ther by single or by double cross-over are isolated
on a kanamycin-containing medium. Then, true gene
disruption mutants resulting exclusively from double
cross-over events are characterized by the loss of a
plasmid born marker tetracyline-resistance in the
.case of pPHU281 . In our hands an efficient gene
disruption requires flanking regions at least equal to
500 bp. Actually, we experienced double cross-over
frequencies between 0.5 and 5% of the total recombi-
nants using suicide constructions with interposon
flanking regions ranging from 450 bp to 2.2 kbp,
respectively.
In bacteria where only a type I NADH-ubiquinone
oxidoreductase is present, such as R. capsulatus and
P. denitrificans, genetic alteration of the type I
NADH-ubiquinone oxidoreductase is expected to al-
ter their ability to grow aerobically. In this respect,
R. capsulatus is a very versatile bacteria able to grow
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under numerous conditions including photo-
w xheterotrophic anaerobiosis 40 . Under these last con-
ditions energization of the bacterial membrane is
realized by the photosystem whereas organic carbon
source and reducing equivalents are provided to the
bacteria in the form of a substrate such as lactate or
malate. Thus, photoheterotrophy looks well-suited to
isolate and to maintain respiratory-deficient mutants.
w xAlong this line, Marrs et al. 41 designed a negative
screening strategy to isolate R. capsulatus respira-
tory-deficient mutants: following exposure to ni-
trosoguanidine, R. capsulatus was cultured aerobi-
cally in the presence of penicillin. This allowed the
counterselection of R. capsulatus strains unable to
grow under dark aerobic conditions. After suppres-
sion of the antibiotic, the still viable cells were
allowed to grow under photoheterotrophic conditions.
Using this screening strategy they successfully iso-
lated several mutants of the respiratory chain. One of
 .those M1 exhibited an altered NADH-ubiquinone
oxidoreductase activity. This M1 mutant was unable
to grow under aerobic conditions but exhibited nor-
mal growth in strictly anaerobic photoheterotrophic
cultures. Thus, to isolate nuo-disruption mutants gen-
erated by KIXX interposon specific insertions in
different R. capsulatus nuo genes, we first chose
photoheterotrophic growth conditions. The different
genes individually targeted in this study were nuoH,
nuoI, nuoJ, nuoK , nuoL, nuoM and nuoN corre-
sponding respectively to ND1, TYKY, ND6, ND4L,
ND5, ND4 and ND2 in the mitochondria. No mutant
could be isolated under anaerobic photoheterotrophic
growth conditions using lactate, malate or succinate
as a carbon source. However, for all the genes tar-
geted, nuo-disruption mutants could be isolated under
w xaerobic conditions 42 . The difference of phenotype
between these mutants and M1 mutant is puzzling.
This observation has now been confirmed by exten-
sive growth studies: nuo-disruption mutants are able
to grow aerobically in the dark on lactate or malate
but are unable to grow photoheterotrophically on
these carbon sources under anaerobiosis. However,
R. capsulatus Complex I-deficient mutants can grow
photoheterotrophically under anaerobiosis, provided
w xDMSO is added to the culture 42 . This phenotype
can be extended to point mutants, such as the C74S
mutant of the NUOI subunit see below and Ref.
w x.27 . To explain the phenotype of R. capsulatus
nuo-disruption mutants, it can be noted that this
phenotype appears remarkably similar to the pheno-
type of R. sphaeroides Rubisco-deficient mutants
w x43 . In this last case, screening for compensatory
mutations led to the isolation of nitrogenase-deregu-
lated mutants. The simplest explanation for this com-
pensatory effect is to consider that nitrogenase drains
the excess of reducing equivalents accumulating in
the absence of carbon dioxide fixation. Actually, the
common characteristic of nitrogenase and DMSO
reductase pathways is that they drain electrons from
ubiquinol. R. capsulatus is known to be very sensi-
w xtive to redox unbalance 44 . This might be associated
with the fact that cyclic photosynthesis requires oxi-
Fig. 3. Tentative metabolic rationalization of the photoheterotro-
phy negative phenotype of nuo-disruption mutants. In R. capsu-
latus, unpoised redox state is known to alter the efficiency of
w xphotosynthetic electron chain 44 . Under photoheterotrophic con-
ditions, lactate or succinate oxidation can lead to an overreduc-
tion of the quinone pool. In the wild type strain, this excess of
reducing equivalents can be transferred from the ubiquinone to
NADq by reverse flow at the level of the Complex I. These
reducing equivalents are then normally dissipated by carbon
dioxide fixation with the participation of the Rubisco. Thus, R.
capsulatus nuo-disruption mutants appear to be unable to poise
the redox state of ubiquinone pool via carbon dioxide fixation.
This control of the quinol pool redox state can be achieved by
alternative electron sinks such as the DMSO reductase, thus
rescuing the nuo-disrupted mutants. Vertical black arrows are
figuring blockade of anaerobic metabolism resulting from Com-
plex I deficiency.
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dized ubiquinone as an acceptor for the electrons of
 .the bacteriochlorophyll Fig. 3 . Thus maintaining all
the ubiquinone pool in a reduced state might glut the
photosynthetic pathway. Under photoheterotrophic
anaerobic conditions, R. capsulatus normally down
regulates the redox poise of its nicotinic cofactor pool
 .NADrNADH and NADPrNADPH by carbon
dioxide fixation with the participation of the Rubisco.
Transfer of reducing equivalents from the ubiquinone
to NADq by reverse flow at the level of the Complex
I might extend this pathway of redox regulation Fig.
.3 . In such a case, R. capsulatus nuo-disruption
mutants would be unable to poise the redox state of
ubiquinone pool via carbon dioxide fixation. A re-
verse flow of electrons at the level of R. capsulatus
w xComplex I has been demonstrated in vitro 45 . The
phenotype of the nuo-disruption mutants brings the
first direct in vivo evidence for such a major involve-
ment of R. capsulatus Complex I in photosynthesis
metabolism.
As noted above, although clearly deficient in their
NADH-ubiquinone oxidoreductase activity, R. capsu-
latus nuo-disruption mutants do grow aerobically on
energy and carbon sources like malate or lactate. The
efficiency of the different carbon sources used for the
cultures in dark aerobic conditions calls for some
comments. Under these conditions malate appears to
be a poor carbon source for the mutants whereas in
the presence of lactate, the growth characteristics of
the mutants are very similar to those of the wild type
strains. This high capacity of the nuo-disruption mu-
tants to grow specifically on lactate was explained by
the demonstration of the existence of an NAD-inde-
 .pendent lactate dehydrogenase iLDH in the mem-
w xbrane of R. capsulatus 42 . This activity is insensi-
tive to all the classical inhibitors of Complex I and
allows transfer of reducing equivalents to the respira-
tory chain directly at the level of the quinone pool.
This iLDH activity in R. capsulatus is very fortu-
nate: indeed, in P. denitrificans, Complex I appears
to be a vital enzyme. Although the insertion of E.
coli type II NDH was a very smart way to overcome
the apparent impossibility to obtain Complex I al-
w xtered mutants 46 , the presence of a type II NDH
activity in the resulting mutants could lead to compli-
cations in complementation experiments and for en-
zymatic studies of the different mutants thus con-
structed. In this respect, R. capsulatus constitutes a
better model for mutagenesis and complementation
studies of the type I NDH.
At the biochemical level, disruption of any of the
seven R. capsulatus nuo genes targeted so far abol-
ishes both NADH-oxidase and deamino-NADH-ferri-
cyanide activities at the level of R. capsulatus mem-
branes. Furthermore, these activities cannot be evi-
denced in concentrated cytosolic fractions of the
nuo-disruption mutants. This suggests that partially
active subcomplexes are not present either in chro-
matophores or in cytosol concentrates of our mutants.
In N. crassa, chloramphenicol inhibition of the
biosynthesis of the mitochondrially-encoded ND sub-
units, led to the assembly of a catalytically active
subcomplex composed of about 16 subunits and pre-
senting NADH-ubiquinone oxidoreductase activity
w x47 . This contrasts with the enzymatic properties of
our nuo-bacteria disruption mutants. Actually, im-
munochemical characterization of these mutants
shows that noticeable amounts of the peripheral sub-
units NUOC, NUOD, NUOE, as well as subunits
NUOI and NUOJ can still be found in the membranes
w xof the different nuo-disruption mutants 28 . How-
ever, the apparent variability in the amount of these
subunits suggests that they are not stoichiometri-
cally-associated in a single inactive subcomplex. Sim-
ilarly, absence of assembly of Complex I was also
noticed in human cell line mutants lacking the mito-
chondria-encoded subunits ND4 and ND5 due to
w xframeshift mutations 48,49 .
Gene disruption is a powerful way to address the
 .function if any of the orfs identified in R. caspula-
tus nuo operon. We thus constructed mutants NU6K1
and W1, respectively, disrupted in R. capsulatus urf6
w xand urf7 28,27 . These orfs are located between
nuoH and nuoI and between nuoI and nuoJ, respec-
 .tively Fig. 1 . They are not present in E. coli operon
w x  .8 and only urf7 has an equivalent urf6 in P.
w xdenitrificans 9,50 . In this last case, based on its
similarity with the gamma muconolactone decarbox-
ylase, Yagi proposed that the protein encoded by P.
denitrificans urf6 might be involved in some regula-
tion dependent on lactone metabolism. In such a case,
the presence of this orf in P. denitrificans and R.
capsulatus might correspond to a specific metabolic
adaptation of these bacteria which is absent in E.
coli. In a similar way, the specific presence of urf1,
urf2, urf3, urf4 and urf6 in R. capsulatus with no
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homologous equivalent even in P. denitrificans might
be related to the peculiarity of R. capsulatus photo-
synthetic metabolism, i.e., the physiological function-
ing of type I NDH in reverse flow. However, mutants
NU6K1 and W1 have a phenotype identical to wild
type in all the growth conditions tested. Furthermore,
contrary to the other disruption mutants, NU6K1 and
W1 display, respectively, 51 and 103% of the wild
type Complex I activity. For us, the partial decrease
of Complex I activity in NU6K1 can be attributed to
a moderate polar effect of the KIXX interposon.
Thus, the present observations strongly indicate that
these urf6 and urf7 are not essential for the biosyn-
thesis of Complex I either under heterotrophic aero-
bic conditions or under photoheterotrophic condi-
tions. On the other hand, several trials to disrupt
urf242 which is located immediately downstream of
the nuo operon proved unsuccessful. Whereas KIXX
insertion in the nearby nuoN gene was easily gener-
ated, only single recombinants orientated in the same
transcription orientation could be isolated unpub-
.lished results . Such a single cross-over allows the
reconstruction of a normal copy of urfR242. This
suggests that urfR242, which has a highly conserved
w xhomolog in P. denitrificans 50 , is encoding an
essential protein in R. capsulatus. The high similarity
of the protein encoded by urfR242 with E. coli birA
w xproduct 13 suggests that this protein must be in-
volved in the biotinylation process in R. capsulatus.
We took advantage of the innocuity of urf7 dis-
ruption on the Complex I biogenesis and activity to
develop a strategy to generate point mutants altered
at the level of the two putative Fe–S cluster insertion
motifs of the NUOI subunit.
3.2. Generation of point mutants altered in the NUOI
subunit of R. capsulatus Complex I
The unambiguous assignment of all the Fe–S clus-
ters to the different subunits of Complex I has not yet
been completed. Due to its rather high midpoint
potential and to the dependance of this potential upon
pH, the N2 center is considered to play a key role in
the coupling between electron and proton fluxes. The
two most probable candidates to harbor cluster N2
 .  .are the PSST NUOB subunit and the TYKY NUOI
subunit. The characteristics of subunit PSST have
been discussed in Section 2.1. Highly conserved sub-
units identical to the bovine TYKY subunit, were
w x w xalso found in human 51 , in N. crassa 52 , in
Trypanosoma brucei kinetoplast DNA-encoded sub-
. w x w xunit 53 , in the cyanobacterium Synechocystis 54 ,
 . w xin plant mitochondria nuclear-encoded subunit 55
and in different bacteria such as R. capsulatus, P.
w xdenitrificans, T. thermophilus and E. coli 6,8–10 .
In an attempt to get more information about the role
NUOI plays in the R. capsulatus Complex I and to
 .  .try to define which Fe–S cluster s is are bound to
this subunit, we mutagenized the R. capsulatus nuoI
gene so as to generate a set of NUOI missense
mutants. In the Complex I field, in vivo mutagenesis
has been already experienced in a number of species
like N. crassa, Aspergillus niger or P. denitrificans
w x56–60,46 . But invariably, only gene knockouts have
been performed in vivo till now. Alternative more
refined genetic studies were performed on P. denitrif-
icans NQO2 or bovine mitochondrial 24 kDa subunit
using site-directed mutagenesis, but these were only
w xconducted on the overexpressed protein 61,62 . In
the case of R. capsulatus, the authors have developed
an in vivo mutagenesis approach: nuoI missense
mutations were introduced in R. capsulatus either by
complementation of a mutant strain with deleted nuoI
 .gene DnuoI or directly at the level of the bacterial
w xchromosome by gene recombination 27 . A panel of
mutants altered at the level of the cysteine residues of
NUOI was generated. The mutant C74S produced by
replacement of cysteine number 74 by a serine and
the C67S mutant generated by replacement of cys-
teine number 67 are representative of this study.
Similar to the nuo-disruption mutants presented
above, C74S mutant was totally unable to grow under
photosynthetic and anaerobic conditions whereas mu-
tant C67S grew normally under these conditions.
Photosynthetic capacities of C74S mutant were re-
stored by transcomplementation with a plasmid con-
trolling the expression of the wild type nuoI gene
only. The difference of C67S mutant membranes with
C74S mutant membranes is that C74S mutant mem-
branes catalyzed NADH oxidation coupled with oxy-
gen consumption at a very low rate and the NADH
oxidase and deamino-NADH-ferricyanide oxido-
reductase activities were nearly abolished. EPR anal-
ysis clearly indicated that both the N1 and N2 clus-
ters are not significantly assembled at the level of the
w xmembranes in the C74S mutant 27 . By immunode-
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tection, the authors also found that C74S mutant
membranes were nearly completely depleted of the
major peripheral subunits. However, the total amount
 .of the NUOJ subunit ND6 equivalent was found to
be comparable to that detected in the wild type strain
membranes. This loss of peripheral subunits was
concomitant with the disappearance of the Complex I
Fe–S clusters from the cytoplasmic membranes and
clearly indicated that proper assembly of the R.
capsulatus Complex I strictly requires the presence
of an intact NUOI subunit. The presence of notice-
able amounts of NUOI subunit in the C74S mem-
branes in the absence of the NUOC, D, E, F shows
that NUOI is indeed able to bind directly to the
membrane or to interact with the Complex I subdo-
main assembled in the membrane. These observations
on C74S mutant support the idea that NUOI is lo-
cated at the junction between the membranous do-
main and the matricial domain where it may play a
critical role in the assembly process between the two
w xmain parts of Complex I 27 . Probable insertion of
 .the NUOI or equivalent subunits into the membrane
has been postulated in two species: in E. coli, where
the N-terminal part of the subunit has been hypothe-
w xsized to be a transmembranous domain 8 and in T.
brucei, where both the hydrophobic N and C-termini
have been reported as putative membrane-spanning
w xdomains 53 . Unlike these two proteins, R. capsula-
tus NUOI homolog subunit does not exhibit similar
hydrophobic features. The possibility still remains,
however, that in the C74S NUOI mutant, the mutated
NUOI subunit still has some affinity for the ND-like
membranous anchoring proteins.
NUOI displays a marked similarity with ferredox-
w xins bearing two 4Fe–4S cluster-binding motifs.
Thus, it is worthwhile making a comparison between
our mutagenesis experiments and those performed
w xwith the 2= 4Fe–4S ferredoxin of Clostridium
pasteurianum where a number of mutations at the
level of the fourth cysteine of the first cysteine
canonical motif corresponding to Cys74 in R. capsu-
. w xlatus NUOI have been performed 63 . Expression
of this mutated gene in E. coli led to either the
absence of the ferredoxin or else to an unstable or
poorly active ferredoxin. According to the determined
w x3D structures of the 2= 4Fe–4S bacterial ferredox-
w xins 64 , while being part of the first cysteine se-
quence cluster, the fourth cysteine in this first cys-
Fig. 4. Schematic structure of the NUOI subunit. The position of
the eight highly conserved cysteine residues C64, C67, C70,
.C74, C103, C106, C109, C113 and their role as ligands of the
w xtwo probable 4Fe–4S clusters is shown. Assignment of the
positions of the cysteine groups to the Fe–S clusters was made
w xby comparison of the NUOI subunit to that of 2= 4Fe–4S
bacterial ferredoxins.
teine motif actually participates in the binding of the
second Fe–S cubane with three remote cysteines
 .Fig. 4 . Consequently, the cysteine 74 of R. capsula-
tus NUOI subunit may greatly contribute to the over-
all tertiary structure of the protein by bridging the
two cubanes. Substitution of this residue probably
leads to the expression of an unstable protein, which
is most likely rapidly degraded in the cell.
The C67S mutant largely differs from C74S mu-
tant. First, C67S strain is able to grow under anaero-
biosis. Membranes of C67S display a respiratory
activity up to 43% of the wild type membranes.
Finally, EPR characterization of C67S membranes
demonstrated the presence of N1, N2, N3 and N4
Fe–S clusters. In this case, we reproducibly observed
 .a change in the N1rN2 ratio unpublished data .
These observations were taken as evidence that the
NUOI subunit actually harbors two N2 iron sulfur
clusters. EPR behavior of two such Fe–S cluster is
difficult to predict: ferromagnetic coupling can lead
to EPR silent clusters. Alternatively, spin–spin inter-
action can lead to a splitting of the g lines associated
with nearby ferromagnetic centers. Along this line, in
w xthe bovine Complex I, van Belzen et al. 65 observed
a splitting the g line of cluster 2. Multifrequencyz
analysis of this splitting strongly supports the idea
that it occurs from spin–spin coupling between two
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clusters 2. In agreement with our observation on R.
capsulatus mutant these authors postulated that these
two clusters 2 were actually associated with the
w xbovine TYKY subunit 65,17 .
3.3. Reproduction of one human pathological alter-
ation of nd1 gene in R. capsulatus
The association of discrete alterations of mitochon-
drial nd genes with human neuropathies such as
Leber’s disease has been largely documented and is
reviewed by Shapira in the present issue. However,
the biochemical effects of these genetic alterations on
Complex I remain largely uncertain because high
mutation rate of mitochondrial genome generates a
high degree of heterogeneity and also because mito-
chondrial Complex I is encoded both by mitochon-
drial and nuclear genomes. As a consequence, the
impact of a mitochondrial mutation can be dependent
on the nuclear background. This is illustrated for
example, by the large phenotypic variability observed
in some Leber’s cases spontaneous recovery, age of
.disease onset, . . . associated with the same primary
mtDNA mutation. As demonstrated in the case of
mutation leu207“arg affecting the subunit a of the
human mitochondrial F F ATPase, reconstruction of1 0
a human mtDNA mutation in a prokaryotic model
system can greatly help to further characterize the
w xbiochemical effect of the alteration 66 . For these
reasons, bacterial NDH appears an interesting model
to reproduce, in a genetically homogenous back-
ground, mitochondrial pathological point mutations
that affect Complex I.
The G“A transition at position 3460 of mtDNA
which leads to the replacement of alanine residue at
position 52 of human subunit ND1 by a threonine is a
major primary mutation associated with Leber’s dis-
w xease. When tested with decylubiquinone 67 or unde-
w xcylubiquinone 68 , the Complex I of patients’ mito-
chondria exhibit a 20–50% decrease of the NADH-
w xubiquinone oxidoreductase activity 67,68 . The in-
creased inhibitory effect of short chain quinones on
the Complex I enzymatic activity of patients’ mito-
chondria suggests that the mutation induces an alter-
w xation in the quinone binding site 67 . A small de-
crease in sensitivity to rotenone was also observed by
w xsome authors 68 . On the other hand, the efficiency
of oxidative phosphorylation and of proton transloca-
tion by Complex I is unaffected in ND1r3460 mu-
w xtant cells 67 . Likewise, the turnover number of
Complex I and respiration rate are not significantly
limited during respiration with NADq-linked sub-
w xstrates 67 . The discrepancies which can be found in
the literature for the biochemical alterations associ-
ated with this mutation may have several reasons.
Beside the different nature of the biological material
used or the enzymatic activities assayed, this can also
be due in part to differences in the genetic back-
ground of the mutation and to the difficulty to define
a matched ‘wild’ reference.
Alanine residue 52 of human ND1 is conserved in
the corresponding R. capsulatus NUOH subunit
 .alanine residue 65 . In this regard, R. capsulatus
NDH can be considered as a reference system since
the mutation can be introduced in a controlled genetic
background i.e., mutant and wild type strain differ-
.ing only by this mutation . Homologous recombina-
tion was used to substitute either a Ala65“Thr
mutated or a wild type copy of the nuoH gene for the
disrupted nuoH gene in the mutant NHK1. In both
cases, reinsertion of the nuoH gene by double cross-
over led to the recovery of a wild type phenotype and
NDH activity. Comparative studies between both re-
combinants did not show any alteration of the growth
phenotype of the resulting NUOHr‘3460’ mutant on
carbon sources such as lactate or malate, under aero-
biosis or anaerobiosis. The NADH-ferricyanide oxi-
doreduction activity was unchanged in the mutant
thus indicating that the amount of Complex I was not
decreased in mutant membranes. As was observed
with mitochondrial mutants, a small but significant
decrease in the NADH oxidase activity of the R.
capsulatus NUOHr‘3460’ mutant was reproducibly
obtained. Mutant activity amounted to 80qry5%
of the wild type activity. Furthermore, no difference
in the sensitivity of the NADH oxidase to the in-
hibitors piericidin or rotenone could be evidenced
when comparing the mutant and the wild type NADH
oxidases in R. capsulatus. This study conducted in a
controlled genetic background confirms that the ef-
fect of the NUOHr‘3460’ mutation on the overall R.
capsulatus Complex I function is not very dramatic.
This is in agreement with conclusions indicating that
Complex I-dependent respiration is modestly reduced
in lymphoblastoid cell lines harboring the ND1r3460
w xmutation 67 . While no definitive conclusions
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emerged from these experiments as to the precise
biochemical defect associated with the ND1r3460
mutation in Leber’s disease pathogeny, these results
indicate however that R. capsulatus Complex I repre-
sents an appropriate model which may become even
more valuable once this enzyme is obtained in a
purified form.
3.4. Isolation of piericidin-resistant mutants
A better knowledge of the structure of the quinone
binding sites is mandatory to progress in the elucida-
tion of Complex I mechanism. However, very few
experimental approaches are available to tackle this
subject. Inhibitors such as rotenone and piericidin
seem to bind at or close to the quinone binding sites
of Complex I. Thus, characterization of the binding
sites for these inhibitors is essential for the elucida-
tion of the proton pumping mechanism. Isolation of
inhibitor-resistant mutants constitutes an original ap-
proach to characterize directly the inhibitor binding
sites of Complex I. Such an approach was first tried
in eukaryote systems like human and Drosophila cell
lines. Human cell lines resistant to rotenone have
w xbeen isolated by Hofhaus and Attardi 49 . However,
these resistant cell lines proved deficient in NADH-
dependent respiration and their resistance did not
appear related to Complex I. Similarly, resistance to
rotenone induced in Drosophila cell lines was associ-
ated with a protein which binds and neutralizes the
w xinhibitor rather than a true Complex I alteration 69 .
As presented above, a slight decrease of rotenone-
sensitivity in human Complex I was also observed in
patients’ samples with pathological mutations on ND1
w xand ND4 genes 68 . Furthermore, photoaffinity la-
belling of Complex I with radioactive azidomorphi-
genin or dihydrorotenone led to the labelling of the
w xND1 subunit 70,71 . All these data point to ND1 or
ND4 as candidates for location of a rotenone binding
site. Since in the eukaryotes, the ND genes are not
easily amenable to genetic studies, bacterial systems
appear especially interesting to develop such studies.
Compared to R. capsulatus or P. denitrificans, E.
coli displays a rather poor sensitivity to most of the
w xinhibitors targeting mitochondrial Complex I 72 .
This can be tentatively related to the fact that the
cytoplasmic membrane of E. coli contains mainly
demethylmenaquinone-8, menaquinone-8 and benzo-
Table 2
Sensitivity of the NADH oxidase activity of wild type strain and
piericidin-resistant mutant membranes to different Complex I
inhibitors
Inhibitors Wild type Mutants I50
ratio
Piericidin max. inhibition )95% 95%
I 0.45 nM 8 nM 1850
Rotenone max. inhibition )95% 95%
I 100 nM 1.2 mM 1250
Rolliniastatin-2 max. inhibition )95% 95%
I 100 nM 100 nM 150
Capsaicin max. inhibition 80% 80%
I 0.1 mM 0.1 mM 150
NADH oxidase activities were recorded spectrophotometrically
with 0.1 mg of membranes.
w xquinone Q8 73 whereas the mitochondria, as well as
w xR. capsulatus 74 contain exclusively the ubiquinone
Q10. Thus, E. coli does not seem to constitute the
best model for the study of Complex I quinone and
related inhibitor binding sites. This prompted us to
take advantage of our bacterial system to try and
isolate piericidin-A-resistant mutants. The choice of
 .piericidin was dictated by several considerations: i
piericidin is one of the most potent inhibitors both for
 .mitochondrial Complex I I s1 nM and for R.50
 .  .  .capsulatus NDH I s0.45 nM Table 2 , ii both50
NADH-driven respiration and NADH oxidase activi-
ties borne by R. capsulatus membranes are at least
 .95% sensitive to piericidin and iii among the differ-
ent Complex I inhibitors, piericidin displays a strik-
ing structural similarity with ubiquinone.
We have reported above that R. capsulatus Com-
plex I-deficient mutants are unable to grow photo-
synthetically under anaerobiosis. Similarly, we first
thought that blockade of Complex I by piericidin
would lead to a similar growth deficiency under
photosynthetic growth conditions. Indeed, piericidin
concentrations up to 10 mM induce a 3–5-day retar-
dation of the growth on solid medium under photo-
synthesis. However, under these conditions, pieri-
cidin growth inhibition did not look stringent enough
to allow an efficient screening for piericidin-resistant
mutants. The apparent discrepancy between these
observations and the phenotype described above for
Complex I-deficient mutants might be explained in
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different ways; one of which might be that anoxy-
genic phototrophic bacteria such as R. capsulatus are
w xable to photodegrade aromatic toxics 75 . After sev-
eral other unsuccessful trials, we designed an original
double inhibitory screening procedure based on the
 .following rationale Fig. 5 . In aerobic growth condi-
 .tions, inhibition of Complex III complex brc1 by
myxothiazol is not sufficient to prevent the bacterial
growth. This is mainly due to the presence of an
alternative quinol oxidase in the cytoplasmic mem-
w x  .brane of R. capsulatus 76 Fig. 5 . However, our
nuo-disruption mutants do not grow aerobically with
malate as a carbon source in the presence of 10 mM
Fig. 5. Metabolic rationale of the piericidin-resistance screening
procedure. Under aerobic growth conditions, inhibition of Com-
plex I by piericidin is not sufficient to prevent the bacterial
growth. Under these conditions, membrane energization results
from proton pumping by Complex III and IV. Similarly, inhibi-
tion of Complex III by myxothiazol alone is not sufficient to
prevent the bacterial aerobic growth. Under these conditions, the
electron flow through Complex I and alternative quinol oxidase
generates a vital membrane potential. Since the nuo-disruption
mutants do not grow aerobically in the presence of myxothiazol,
most of the energization of the cytoplasmic membrane under
such conditions must result from proton pumping at the level of
Complex I. Accordingly, when Complex I and Complex III are
blocked by the combination of piericidin and myxothiazol, ener-
gization of the bacterial membrane is prevented and only mutants
resistant to either of the two inhibitors are able to grow. Also, as
myxothiazol blocks cyclic photosynthesis, mutants resistant to
this inhibitor can be discriminated by their ability to grow
photosynthetically in the presence of this inhibitor.
myxothiazol. This suggests that the alternative oxi-
dase pathway by its own is not sufficient to allow a
normal bacterial growth. Wild type strain grown on
malate in the presence of piericidin must experience a
metabolic stress similar to that experienced by Com-
plex I-deficient mutants. Therefore, in a medium
 .containing both piericidin 2.5 mM and myxothiazol
 .10 mM and malate as a carbon source, only bacteria
resistant to one of the two inhibitors can grow. As
myxothiazol fully inhibits photosynthetic growth of
R. capsulatus by blockade of the cyclic photosynthe-
sis, it is easy to identify mutants resistant to this
inhibitor due to their ability to grow in the presence
of myxothiazol under photoheterotrophy. Actually,
about 90% of the colonies isolated in the myxothia-
.zolqpiericidin screening appeared to be myxothia-
zol-resistant but the remaining mutants proved clearly
sensitive to myxothiazol and resistant to piericidin.
Two independent experiments led to two different
types of mutants. A first group demonstrating a rather
 .low resistance factor 2–3 times was not further
studied. We concentrated on the other set of mutants
which displayed an apparent decrease of piericidin-
 .sensitivity at least 18 times higher I s8 nM50
 . w xTable 2 77 . As discussed above, in the mitochon-
drial system, survey of the literature pointed to sub-
units ND1 and ND4 as the main candidates for
quinone and rotenone binding sites. However, se-
quencing demonstrated that the mutation responsible
for piericidin-resistance in our mutants is not borne
by these subunits.
Enzymatic studies have demonstrated the existence
of at least three classes of Complex I inhibitor bind-
ing sites but this classification remains uncertain and
sites appear to somehow overlap see Degli Esposti’s
contribution in this issue for a review on the inhibitor
.binding sites . Furthermore, the relationship between
these different types of sites and the ubiquinone
binding sites remains unclear. Our genetic study con-
stitutes an original alternative to characterize directly
the inhibitor binding sites of Complex I. Piericidin is
considered to bind to two different sites, one of these
w xis also the rotenone binding site 78 . The piericidin-
resistant mutants are also clearly resistant to rotenone
 .Table 2 but display an unmodified sensitivity to
w xrolliniastatin-2 or capsaicin 77 . In the light of the
present knowledge on Complex I inhibitor binding
sites, the simplest explanation of our data is to as-
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sume that our mutants would be altered at a site
shared by rotenone and piericidin but not by cap-
saicin and rolliniastatin. The great variability of struc-
ture of the different Complex I inhibitors suggests
that the quinone and inhibitors binding domains might
rather represent a large interactions area shared by
different inhibitors rather than a well-defined binding
site. Thus, the promising genetic approach presented
here is still in its infancy and has to be extended by
the isolation and characterization of resistant mutants
against other Complex I inhibitors to really get a
realistic representation of Complex I inhibitor bind-
ing sites.
4. Conclusions
Among bacterial NDH, R. capsulatus Complex I
constitutes an interesting model for the study of
Complex I: compared to E. coli NDH, the subunits
of R. capsulatus Complex I are far more homologous
to the mitochondrial enzyme. Similarly, the identified
EPR signals associated with R. capsulatus as well as
P. denitrificans and R. sphaeroides enzymes com-
pare well with those of mitochondrial Complex I
w x25,28 . The main limitation of this system is the
instability of the complex that has precluded so far
the isolation of an intact solubilized enzyme. On the
other hand, this system presents several attractive
advantages. First, the efficiency of proton pumping of
R. capsulatus Complex I has been demonstrated for
w xquite a long time 5 . Thus, despite its simplicity, this
bacterial NADH-ubiquinone oxidoreductase must
function essentially as the mitochondrial enzyme. It
constitutes a kind of minimal system to study the
fundamental enzymatic mechanism of this type of
enzyme. The difference with E. coli and R. capsula-
tus is that the absence of a type II NADH-ubiquinone
oxidoreductase in R. capsulatus simplifies genetic
and enzymatic studies. Powerful genetic tools have
been developed to manipulate the genome of R.
w xcapsulatus 34 and this allows the development of
genetic approaches hardly accessible with mitochon-
drial systems especially for the mitochondria-encoded
ND subunits. In the case of R. capsulatus, its versa-
tile metabolism and the presence of a NADH-inde-
pendent lactate dehydrogenase bypassing the Com-
plex I allows easy isolation of Complex I-deficient
mutants as demonstrated by the construction of nuo-
disruption mutants and several missense mutants
w x27,28,42 . Reconstruction of pathological mtDNA
mutations in R. capsulatus can be easily achieved.
As an example, construction of mutation ND1r‘3460’
in the controlled genetic background provided by R.
capsulatus confirmed the observations reported for
the human Complex I. The accessibility to a genetic
approach is also of interest for the study of the
quinone and inhibitor binding sites. In this regard,
again different to E. coli, R. capsulatus membranes
contain the same ubiquinone Q10 as the mitochon-
drial system. As illustrated by the study of R. capsu-
latus piericidin-resistant mutants, this original and
powerful approach can give essential informations on
the quinone and inhibitor binding sites of Complex I.
Finally, the R. capsulatus system presents one other
major interest not yet exploited in the enzymatic
study of the Complex I: the presence of the bacterial
photosystem allows fast reduction of the quinone
pool and fast energization of the membranes.
w xKlemme et al. 45 demonstrated that R. capsula-
tus Complex I is able to reduce NADq under such
conditions in vitro. Since spectral change of the
carotenoid band also allows fast measurements of the
w xmembrane potential 79 , R. capsulatus membranes
may be used for fast kinetic reverse flow experiments
not possible with other mitochondrial or bacterial
systems. This approach will be developed to further
refine the study of the different Complex I-deficient
mutants already constructed in R. capsulatus. All
these considerations demonstrate that R. capsulatus
Complex I has its own specificities complementary to
the other studied Complexes I. Integration of all the
advantages of the different systems will allow deci-
sive progress to be made in the understanding of this
sophisticated enzyme.
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